AKER BIOMARINE ASA (AKBM.OL) Stock Price & Overview

OSL:AKBMNO0010886625

Current stock price

104.8 NOK
-3.2 (-2.96%)
Last:

The current stock price of AKBM.OL is 104.8 NOK. Today AKBM.OL is down by -2.96%. In the past month the price decreased by -0.37%. In the past year, price increased by 119.51%.

AKBM.OL Key Statistics

52-Week Range49.3 - 118
Current AKBM.OL stock price positioned within its 52-week range.
1-Month Range97.7 - 118
Current AKBM.OL stock price positioned within its 1-month range.
Market Cap
9.193B
P/E
N/A
Fwd P/E
37.98
EPS (TTM)
-2.29
Dividend Yield
N/A

AKBM.OL Stock Performance

Today
-2.96%
1 Week
+2.47%
1 Month
-0.37%
3 Months
+8.11%
Longer-term
6 Months +23.57%
1 Year +119.51%
2 Years +53.85%
3 Years +170.34%
5 Years +21.62%
10 Years N/A

AKBM.OL Stock Chart

AKER BIOMARINE ASA / AKBM Daily stock chart

AKBM.OL Technical Analysis

ChartMill assigns a technical rating of 10 / 10 to AKBM.OL. When comparing the yearly performance of all stocks, AKBM.OL is one of the better performing stocks in the market, outperforming 93.28% of all stocks.


Chartmill TA Rating
Chartmill Setup Rating

AKBM.OL Fundamental Analysis

ChartMill assigns a fundamental rating of 3 / 10 to AKBM.OL. Both the profitability and financial health of AKBM.OL have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend

AKBM.OL Earnings

Next Earnings DateApr 30, 2026
Last Earnings DateFeb 12, 2026
PeriodQ4 / 2025
EPS Reported
Revenue Reported
EPS Surprise %
Revenue Surprise -10.80%

AKBM.OL Forecast & Estimates

9 analysts have analysed AKBM.OL and the average price target is 124.95 NOK. This implies a price increase of 19.23% is expected in the next year compared to the current price of 104.8.

For the next year, analysts expect an EPS growth of 235.29% and a revenue growth 11.74% for AKBM.OL


Analysts
Analysts82.22
Price Target124.95 (19.23%)
EPS Next Y235.29%
Revenue Next Year11.74%

AKBM.OL Groups

Sector & Classification

Index Membership

AKBM.OL Financial Highlights

Over the last trailing twelve months AKBM.OL reported a non-GAAP Earnings per Share(EPS) of -2.29. The EPS decreased by -111.62% compared to the year before.


Income Statements
Revenue(TTM)218.10M
Net Income(TTM)-22.90M
Industry RankSector Rank
PM (TTM) N/A
ROA -5.95%
ROE -15.91%
Debt/Equity 1.11
Chartmill High Growth Momentum
EPS Q2Q%61.2%
Sales Q2Q%6.15%
EPS 1Y (TTM)-111.62%
Revenue 1Y (TTM)-4.68%

AKBM.OL Ownership

Ownership
Inst Owners6.3%
Shares87.72M
Float9.37M
Ins Owners6.14%
Short Float %N/A
Short RatioN/A

About AKBM.OL

Company Profile

AKBM logo image Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.

Company Info

IPO: 2020-07-06

AKER BIOMARINE ASA

Oksenoyveien 10, P.O. Box 496

Lysaker AKERSHUS NO

Employees: 258

AKBM Company Website

AKBM Investor Relations

Phone: 4724130000

AKER BIOMARINE ASA / AKBM.OL FAQ

Can you describe the business of AKER BIOMARINE ASA?

Aker BioMarine AS is a biotech innovator and Antarctic krill-harvesting company, which engages in the development of krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company consists of two business segments: Ingredients and Brands. Under The Ingredients segment, the Company develops krillbased ingredients for human applications in the nutraceutical and dietary supplement space, and animal feed applications for aquaculture and pet food. Under The Brands segment, the Company has two companies: Lang Pharma Nutrition and Epion Brands. Lang Pharma Nutrition is a full service, mass market private label and corporate brand manufacturer within supplements. Epion Brands has its own consumer brand in the US market, Kori, being on the shelves of retailers. Aker BioMarine’s focus on sustainability inspired the launch of AION by Aker BioMarine, a circularity company dedicated to helping companies to recycle and reuse waste.


What is the stock price of AKER BIOMARINE ASA today?

The current stock price of AKBM.OL is 104.8 NOK. The price decreased by -2.96% in the last trading session.


Does AKER BIOMARINE ASA pay dividends?

AKBM.OL does not pay a dividend.


What is the ChartMill rating of AKER BIOMARINE ASA stock?

AKBM.OL has a ChartMill Technical rating of 10 out of 10 and a ChartMill Fundamental rating of 3 out of 10.


What sector and industry does AKER BIOMARINE ASA belong to?

AKER BIOMARINE ASA (AKBM.OL) operates in the Consumer Staples sector and the Food Products industry.


How many employees does AKER BIOMARINE ASA have?

AKER BIOMARINE ASA (AKBM.OL) currently has 258 employees.


Can you provide the market cap for AKER BIOMARINE ASA?

AKER BIOMARINE ASA (AKBM.OL) has a market capitalization of 9.19B NOK. This makes AKBM.OL a Mid Cap stock.